Cat Number: API209216239

Entecavir Monohydrate

APIs
CAS Number
209216-23-9
Synonyms
Entecavir hydrate
entecavir monohydrate
Entecavir (monohydrate)
Entecavir hydrate (JAN)
Description
A synthetic analogue of 2'-deoxyguanosine, entecavir is a nucleoside reverse transcriptase inhibitor with selective antiviral activity against hepatitis B virus. It is phosphorylated intracellularly to the active triphosphate form, which competes with deoxyguanosine triphosphate, the natural substrate of hepatitis B virus reverse transcriptase, inhibiting every stage of the enzyme's activity, although it has no activity against HIV. Enteclavir is used for the treatment of chronic hepatitis B. It has a role as an EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor and an antiviral drug.
Molecular Weight
295.29
Molecular Formula
C12H17N5O4
SMILES
C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N.O
EINECS
606-668-5
Appearance
White Powder
Boiling Point
661.4℃ at 760 mmHg
Density, g/cm3
1.81
Melting Point
31℃
Specification
USDMF25200
R1-CEP 2016-152-Rev 00
CADMF 2013-061
JP 227ME10302
TW DMF(64)0702
Y20170000439
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top